Why does null hypothesis testing matter for POI target validation?

Null hypothesis testing in the murine POI model enables objective evaluation of whether candidate interventions significantly alter gastrointestinal transit or immune infiltration compared to controls. This statistical rigor is essential for validating mechanistic targets and reducing false positives in early discovery. Reliable hypothesis testing supports confident progression of therapeutic candidates.

How does independent variable isolation fit the intestinal manipulation protocol?

The protocol controls surgical technique and animal care to isolate the effects of intestinal manipulation as the independent variable. This isolation ensures that observed changes in motility or inflammation are attributable to the intervention, supporting mechanistic clarity and reproducibility. Such control is vital for robust discovery-stage findings.

What do quantitative gastrointestinal transit measurements enable in POI studies?

Quantitative assessment of FITC-dextran transit provides objective, reproducible data on gastrointestinal motility impairment following surgery. These measurements enable comparison of intervention efficacy and facilitate data-driven decision-making in compound screening and target validation. Quantitative outputs are critical for cross-study and cross-team comparability.

Why are replication requirements important for cross-functional POI research?

Replication of the POI model with standardized procedures ensures that findings are consistent and transferable across research teams. This reproducibility underpins cross-functional collaboration, enabling reliable data integration and portfolio-level decision-making. Consistent replication reduces experimental variability and supports enterprise-wide confidence in preclinical results.

What statistical analysis capabilities are required before POI model implementation?

Implementation of the POI model requires statistical tools for analyzing differences in gastrointestinal transit, immune cell infiltration, and tissue pathology between groups. Capabilities must include hypothesis testing, variance analysis, and reproducibility assessment to ensure robust interpretation of experimental outcomes. These analyses are foundational for advancing candidates through the discovery pipeline.

Pooperacyjny model mysiej niedrożności jelit

1.9K wyświetleń

Cytowany 4 razy

04:26 min

12 lipca 2024

10.3791/66465-v

12 lipca 2024

1.9K wyświetleń

Dan Tian^*¹^,²^,³^,⁴^,⁵ , Bihan Liu^*¹^,²^,³^,⁴^,⁵ , Shiyang Huang²^,³^,⁴^,⁵^,⁶ , Wen Shi²^,³^,⁴^,⁵^,⁶ , Yue Tian²^,³^,⁴^,⁵^,⁶ , Yingchi Yang¹^,²^,³ , Dong Zhang⁷^,⁸ , Zhongtao Zhang¹^,²^,³ , Fandi Bu⁹

¹General Surgery Department, Beijing Friendship Hospital, Capital Medical University, ²National Clinical Research Center for Digestive Diseases, ³State Key Lab of Digestive Health, Beijing Friendship Hospital, Capital Medical University, ⁴Immunology Research Center for Oral and Systemic Health, Beijing Friendship Hospital, Capital Medical University, ⁵Beijing Laboratory of Oral Health, Capital Medical University School of Stomatology, ⁶Beijing Clinical Research Institute, ⁷Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, ⁸Beijing Institute of Brain Disorders, Capital Medical University, ⁹Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital, Capital Medical University

^* These authors contributed equally

Opisujemy mysi model pooperacyjnej niedrożności jelit generowany przez manipulację jelitową. Funkcję pasażu pokarmowego, zmiany patologiczne i aktywację komórek odpornościowych oceniano 24 godziny po zabiegu.